Leukemia

Latest News

Tambiciclib was well tolerated in patients with acute myeloid leukemia with myelodysplastic-related changes, and no new safety signals were observed.
Tambiciclib Displays Survival Benefit, Enhanced ORR in AML-MRC

April 9th 2025

Tambiciclib was well tolerated in patients with acute myeloid leukemia with myelodysplastic-related changes, and no new safety signals were observed.

Recipients of hematopoietic stem cell transplantation may benefit from psychosocial interventions and supportive care following their procedure.
HSCT Recipients Show Sustained Health Challenges Following Transplant

March 25th 2025

Mipletamig/SOC Achieved Complete Remission Rates in Front-Line AML
Mipletamig/SOC Achieved Complete Remission Rates in Front-Line AML

March 24th 2025

Clinical guidelines aimed at both clinicians and patients seek to educate and include both parties in clinical decision-making processes.
Highlighting Developments and Informing Treatment Planning in CLL Care

March 13th 2025

CHMP Recommends Pirtobrutinib for EU Approval in Pretreated R/R CLL
CHMP Recommends Pirtobrutinib for EU Approval in Pretreated R/R CLL

March 3rd 2025

More News